| 注册
首页|期刊导航|中国药理学通报|中药活性成分干预肝纤维化分子信号通路的研究进展

中药活性成分干预肝纤维化分子信号通路的研究进展

禤传凤 罗伟生 陈国忠 彭卓嵛 康毅 黄瑞 张扬武

中国药理学通报2017,Vol.33Issue(12):1638-1641,4.
中国药理学通报2017,Vol.33Issue(12):1638-1641,4.DOI:10.3969/j.issn.1001-1978.2017.12.003

中药活性成分干预肝纤维化分子信号通路的研究进展

Study of active ingredients of Chinese medicine interfering with molecular signaling pathway of liver fibrosis

禤传凤 1罗伟生 1陈国忠 2彭卓嵛 2康毅 2黄瑞 1张扬武1

作者信息

  • 1. 广西中医药大学第一临床医学院,广西 南宁 530001
  • 2. 广西中医药大学第一附属医院脾胃科,广西 南宁 530001
  • 折叠

摘要

Abstract

The occurrence and progression of hepatic fibrosis are regulated by multicytokines and multiple molecular signal trans-duction pathways in cells. Currently,the molecular signaling pathway is the target for drugs to treat diseases. The study of the active ingredients of Chinese medicine to interfere with the sig-naling pathways of liver fibrosis is a hot topic. In the past ten years,it has been reported that hydroxysafflor yellow A,total flavonoids from litchi seed,ursolic acid,curcumin can interfere the signaling pathway of p38MAPK,TGF-β/ Smad,Wnt,Ras/ERK and Hedgehog liver fibrosis. The research on the active in-gredients of Chinese traditional medicine,which is targeted at signaling pathways,is expected to open new areas for Chinese and western medicine in the treatment of liver fibrosis.

关键词

肝纤维化/p38MAPK/TGF-β/Smad/Ras/ERK/Hedgehog/中药活性成分

Key words

hepatic fibrosis/p38MAPK/TGF-β/ Smad/Ras/ERK/Hedgehog/Hedgehog/active ingredient of TCM

分类

医药卫生

引用本文复制引用

禤传凤,罗伟生,陈国忠,彭卓嵛,康毅,黄瑞,张扬武..中药活性成分干预肝纤维化分子信号通路的研究进展[J].中国药理学通报,2017,33(12):1638-1641,4.

基金项目

国家自然科学基金资助项目(No 8136053,81660779) (No 8136053,81660779)

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文